American Society for Clinical Oncology (ASCO) 2023
ASCO recently held its 2023 conference from June 2-6, 2023. Click the links below to learn about MBC-related reports from this meeting.
- Breastcancer.org (Scroll to items 5 and 6 for MBC news): Highlights from ASCO 2023
- ASCO Daily News (Podcast and Transcript): Capecitabine Dosing, Managing Side Effects from Capecitabine, and Selection of CDK4/6 Inhibitors for MBC
- Practice Update: Changing the Dosing of Capecitabine to Reduce Toxicity
- ASCO Abstract: Artificial Intelligence to Determine HER2 Status
- Practice Update: Flibanserin to Improve Sexual Health in Women With Breast Cancer Who Are Receiving Endocrine Therapy
- Practice Update: ASCO 2023: Outcomes in Older Women With Metastatic Breast Cancer Improving Over Time